Last reviewed · How we verify
Intracochlear application of VSF1.01
At a glance
| Generic name | Intracochlear application of VSF1.01 |
|---|---|
| Sponsor | Hannover Medical School |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Intracochlear Application of VSF1.01 for the Reduction of Cochlear Implant Surgery Related Trauma (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Intracochlear application of VSF1.01 CI brief — competitive landscape report
- Intracochlear application of VSF1.01 updates RSS · CI watch RSS
- Hannover Medical School portfolio CI